JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M505159200 on July 5, 2005

J. Biol. Chem., Vol. 280, Issue 36, 31699-31707, September 9, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/36/31699    most recent
M505159200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robinson, F. L.
Right arrow Articles by Dixon, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robinson, F. L.
Right arrow Articles by Dixon, J. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Phosphoinositide-3-phosphatase MTMR2 Associates with MTMR13, a Membrane-associated Pseudophosphatase Also Mutated in Type 4B Charcot-Marie-Tooth Disease*

Fred L. Robinson{ddagger}§ and Jack E. Dixon{ddagger}¶||**

From the Departments of {ddagger}Pharmacology, Cellular and Molecular Medicine, and ||Chemistry and Biochemistry, The University of California San Diego, La Jolla, California 92093

Charcot-Marie-Tooth disease type 4B (CMT4B) is a severe, demyelinating peripheral neuropathy characterized by distinctive, focally folded myelin sheaths. CMT4B is caused by recessively inherited mutations in either myotubularin-related 2 (MTMR2) or MTMR13 (also called SET-binding factor 2). MTMR2 encodes a member of the myotubularin family of phosphoinositide-3-phosphatases, which dephosphorylate phosphatidylinositol 3-phosphate (PI(3)P) and bisphosphate PI(3,5)P2. MTMR13 encodes a large, uncharacterized member of the myotubularin family. The MTMR13 phosphatase domain is catalytically inactive because the essential Cys and Arg residues are absent. Given the genetic association of both MTMR2 and MTMR13 with CMT4B, we investigated the biochemical relationship between these two proteins. We found that the endogenous MTMR2 and MTMR13 proteins are associated in human embryonic kidney 293 cells. MTMR2-MTMR13 association is mediated by coiled-coil sequences present in each protein. We also examined the cellular localization of MTMR2 and MTMR13 using fluorescence microscopy and subcellular fractionation. We found that (i) MTMR13 is a predominantly membrane-associated protein; (ii) MTMR2 and MTMR13 cofractionate in both a light membrane fraction and a cytosolic fraction; and (iii) MTMR13 membrane association is mediated by the segment of the protein which contains the pseudophosphatase domain. This work, which describes the first cellular or biochemical investigation of the MTMR13 pseudophosphatase protein, suggests that MTMR13 functions in association with MTMR2. Loss of MTMR13 function in CMT4B2 patients may lead to alterations in MTMR2 function and subsequent alterations in 3-phosphoinositide signaling. Such a mechanism would explain the strikingly similar phenotypes of patients with recessive mutations in either MTMR2 or MTMR13.


Received for publication, May 11, 2005 , and in revised form, July 1, 2005.

* This work was supported in part by National Institutes of Health Grant 2R01 DK018024-31 and a grant from the Walther Cancer Institute (to J. E. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Supported by Ruth L. Kirschstein National Research Service Award Postdoctoral Grants 5 T32 HD07203-20 and 1 F32 NS047846-01A1 from the NICHHD and NINDS, National Institutes of Health, respectively.

** To whom correspondence should be addressed: Dept. of Pharmacology, University of California San Diego, School of Medicine, Leichtag Bldg., Rm. 284, 9500 Gilman Dr., La Jolla, CA 92093-0721. Tel.: 858-822-0491; Fax: 858-822-5888; E-mail: jedixon{at}ucsd.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BrainHome page
X. Zhang, C. Y. Chow, Z. Sahenk, M. E. Shy, M. H. Meisler, and J. Li
Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degeneration
Brain, August 1, 2008; 131(8): 1990 - 2001.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
C. Cao, J. M. Backer, J. Laporte, E. J. Bedrick, and A. Wandinger-Ness
Sequential Actions of Myotubularin Lipid Phosphatases Regulate Endosomal PI(3)P and Growth Factor Receptor Trafficking
Mol. Biol. Cell, August 1, 2008; 19(8): 3334 - 3346.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. L. Robinson, I. R. Niesman, K. K. Beiswenger, and J. E. Dixon
Loss of the inactive myotubularin-related phosphatase Mtmr13 leads to a Charcot-Marie-Tooth 4B2-like peripheral neuropathy in mice
PNAS, March 25, 2008; 105(12): 4916 - 4921.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
K. Tersar, M. Boentert, P. Berger, S. Bonneick, C. Wessig, K. V. Toyka, P. Young, and U. Suter
Mtmr13/Sbf2-deficient mice: an animal model for CMT4B2
Hum. Mol. Genet., December 15, 2007; 16(24): 2991 - 3001.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
O. Lorenzo, S. Urbe, and M. J. Clague
Systematic analysis of myotubularins: heteromeric interactions, subcellular localisation and endosomerelated functions
J. Cell Sci., July 15, 2006; 119(14): 2953 - 2959.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. Berger, I. Berger, C. Schaffitzel, K. Tersar, B. Volkmer, and U. Suter
Multi-level regulation of myotubularin-related protein-2 phosphatase activity by myotubularin-related protein-13/set-binding factor-2
Hum. Mol. Genet., February 15, 2006; 15(4): 569 - 579.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. J. Begley, G. S. Taylor, M. A. Brock, P. Ghosh, V. L. Woods, and J. E. Dixon
Molecular basis for substrate recognition by MTMR2, a myotubularin family phosphoinositide phosphatase
PNAS, January 24, 2006; 103(4): 927 - 932.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. Bonneick, M. Boentert, P. Berger, S. Atanasoski, N. Mantei, C. Wessig, K. V. Toyka, P. Young, and U. Suter
An animal model for Charcot-Marie-Tooth disease type 4B1
Hum. Mol. Genet., December 1, 2005; 14(23): 3685 - 3695.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.